Twin Capital Management Inc. acquired a new position in Lam Research Corporation (NASDAQ:LRCX – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,206 shares of the semiconductor company’s stock, valued at approximately $1,099,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. IMG Wealth Management Inc. bought a new stake in Lam Research during the second quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the 2nd quarter worth about $27,000. Sound Income Strategies LLC bought a new stake in Lam Research during the 3rd quarter valued at approximately $41,000. Strategic Wealth Investment Group LLC acquired a new stake in Lam Research in the 2nd quarter valued at approximately $29,000. Finally, Tripletail Wealth Management LLC bought a new position in Lam Research in the 3rd quarter worth approximately $44,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Lam Research Stock Performance
NASDAQ:LRCX opened at $231.01 on Friday. The firm has a market capitalization of $288.48 billion, a PE ratio of 47.34, a price-to-earnings-growth ratio of 2.50 and a beta of 1.78. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $251.87. The firm has a 50-day moving average price of $194.38 and a 200 day moving average price of $150.67.
Lam Research Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio is currently 21.31%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. Royal Bank Of Canada reissued an “outperform” rating and issued a $290.00 price objective (up from $260.00) on shares of Lam Research in a research report on Thursday, January 29th. Dbs Bank raised their price target on shares of Lam Research from $119.40 to $184.20 in a research report on Monday, October 27th. Wall Street Zen lowered shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. B. Riley Financial reiterated a “buy” rating on shares of Lam Research in a research note on Thursday, January 15th. Finally, Oppenheimer restated an “outperform” rating and set a $265.00 price target on shares of Lam Research in a research note on Thursday, January 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $244.57.
Get Our Latest Stock Analysis on Lam Research
Insider Activity
In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.31% of the company’s stock.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam announced a strategic alliance with CEA‑Leti and an internal leadership shift aimed at accelerating AI‑equipment development — investors see this as direct exposure to faster AI capex cycles. Lam Research Targets AI Growth With CEA Leti Deal And Leadership Shift
- Positive Sentiment: Celebrity investor/TV host Jim Cramer publicly endorsed adding LRCX to portfolios, raising retail/institutional interest and trading flows. Lam Research (LRCX) Is the Future, Says Jim Cramer
- Positive Sentiment: Argus and other analysts lifted price targets (Argus to $280) and the sell‑side average implies roughly 30% upside — upgrades and higher targets support buying interest. Argus Increases Lam Research Price Target to $280.00
- Positive Sentiment: Lam declared a $0.26 quarterly dividend (0.5% yield) — modest cash return but signals board confidence in cash flow and capital allocation. Lam Research Corporation Declares Quarterly Dividend
- Neutral Sentiment: Zacks and other screens highlight LRCX as a momentum pick amid recent market weakness — this flags participation from quant/momentum funds but also exposes the stock to volatility in a tech selloff. 3 Momentum Anomaly Stocks to Buy as Tech Rout Spooks Markets
- Neutral Sentiment: Company announced a board addition and COO transition — governance/leadership updates that deserve monitoring but aren’t an immediate revenue driver. Lam Research Announces Board Addition and COO Transition
- Negative Sentiment: Shares had a sharp pullback earlier in the week (noted as “down 10% in two days”), reflecting broader tech/crypto volatility — that recent selling created a short-term risk that some traders are buying into. Down 10 In Two Days, Is Lam Research A Good Buy?
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
- Five stocks we like better than Lam Research
- The buying spree that no one is talking about
- Virtually Limitless Energy
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- NEW LAW: Congress Approves Setup For Digital Dollar?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
